TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. EPS 2020–2025
TScan Therapeutics Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- TScan Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.22, a 15.38% decrease year-over-year.
- TScan Therapeutics Inc. annual eps for 2025 was $1.00, a 12.28% decrease from 2024.
- TScan Therapeutics Inc. annual eps for 2024 was $1.14, a 16.18% decrease from 2023.
- TScan Therapeutics Inc. annual eps for 2023 was $1.36, a 50.55% decrease from 2022.
- TScan Therapeutics Inc. annual eps for 2022 was $2.75.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
TScan Therapeutics Inc. EPS — FAQ
TScan Therapeutics Inc. (TCRX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TScan Therapeutics Inc.'s eps?
TScan Therapeutics Inc. (TCRX) reported eps of $-1.00 for fiscal 2025.
Where can I see TCRX's eps history?
The chart and table above show TScan Therapeutics Inc.'s eps by year and by quarter, including the growth rate.